BioStock: Chordate Medical’s migraine study enters final stage
Since 2018, Chordate Medical has conducted a study on migraine patients to prove clinical efficacy and safety with the nerve modulating treatment method K.O.S. The patient study, conducted in Germany and Finland, is now in its final phase, and the goal is to have an article with the study results submitted to a scientific journal for publication in the spring of 2022.Read the full article at biostock.se: https://www.biostock.se/en/2021/10/chordate-medicals-migraine-study-enters-final-stage/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
Elkem, a global leader in silicon-based advanced materials, today announces that it will test the world’s first carbon capture pilot for silicon smelters at its plant in Rana, Norway. The project has received financial support from Gassnova CLIMIT and is a follow-up to the company’s recently launched climate roadmap to reduce emissions towards net zero while growing supplies to the green transition.The carbon capture pilot is a collaboration between Elkem and Mo Industripark, SINTEF, Alcoa, Celsa, Ferroglobe, SMA Mineral, Norcem, Norfrakalk, Arctic Cluster Team and Aker Carbon Capture.
